findmyKOL

Kerim Kaylan, MD, PhD

Basic profile

University of Chicago

ORCIDNPI
RegionChicago, IL · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Kerim Kaylan is an Endocrinology/Metabolic physician affiliated with University of Chicago. OpenAlex indexes 29 publications with 550 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
29publications

Distinct works indexed by OpenAlex, matched via ORCID.

550citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    58.6%
    Statin17.6%
    Atorvastatin Calcium100%
    Part D27 patients
    Calcium channel blocker15.7%
    Amlodipine Besylate82%Nifedipine Er18%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    23.2%
    Biguanide (metformin)10.3%
    Metformin Hcl65%Metformin Hcl Er35%
    Part D11 patients
    Insulin Analog3.9%
    Lantus Solostar100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    7.3%
    Gabapentinoids4.7%
    Gabapentin100%
    Part D<11 patients
    SSRI2.6%
    Escitalopram Oxalate100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”